A drug developed at UB to treat FOXG1 syndrome has been cleared by the U.S. Food and Drug Administration to begin clinical trials. The agency approved an Investigational New Drug (IND) application for ...
A viral gene therapy developed by University at Buffalo researchers has reversed some brain abnormalities in infant mice with FOXG1 syndrome, a significant step toward one day treating children with ...
Researchers in Taiwan and Belgium developed a lab-based diagnostic workflow that could help doctors predict the severity of a rare childhood brain disorder called FOXG1 syndrome (a rare ...
TAIPEI (Taiwan News) — National Yang Ming Chiao Tung University and National Taiwan University Children's Hospital have collaborated to develop a test that predicts the severity of the rare FOXG1 ...
Glioblastoma (GBM) is the most common and deadly malignant brain cancer, with a median survival of <2 years. GBM displays a cellular complexity that includes brain tumour-initiating cells (BTICs), ...
Soo-Kyung Lee, a neurodevelopmental biologist from the State University of New York at Buffalo, built her career studying transcription factors important for brain development and understanding how ...
A new study conducted by SISSA's Laboratory of Cerebral Cortex Development and recently published in BMC Biology has led to a surprising revelation about the role of the FOXG1 gene: not only does it ...
Get the Well Enough newsletter with Harry Bullmore for tips on living a healthier, happier and longer life Get the Well Enough email with Harry Bullmore By the time her mother received the doctor’s ...
It works like a very fine "molecular knob" able to modulate the electrical activity of the neurons of our cerebral cortex, crucial to the functioning of our brain. Its name is Foxg1, it is a gene, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results